4o17
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 4o17 is ON HOLD Authors: Oh, A., Coons, M., Brillantes, B., Wang, W Description: Structural Basis for Resistance to Diverse Classes of NAMPT Inhibi...) |
|||
| (8 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors== | |
| + | <StructureSection load='4o17' size='340' side='right'caption='[[4o17]], [[Resolution|resolution]] 1.82Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[4o17]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4O17 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4O17 FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.82Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=PO4:PHOSPHATE+ION'>PO4</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4o17 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4o17 OCA], [https://pdbe.org/4o17 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4o17 RCSB], [https://www.ebi.ac.uk/pdbsum/4o17 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4o17 ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/NAMPT_HUMAN NAMPT_HUMAN] Catalyzes the condensation of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway (By similarity). | ||
| - | + | ==See Also== | |
| - | + | *[[Phosphoribosyltransferase 3D structures|Phosphoribosyltransferase 3D structures]] | |
| - | + | __TOC__ | |
| + | </StructureSection> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Brillantes B]] | ||
| + | [[Category: Coons M]] | ||
| + | [[Category: Oh A]] | ||
| + | [[Category: Wang W]] | ||
Current revision
Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors
| |||||||||||
Categories: Homo sapiens | Large Structures | Brillantes B | Coons M | Oh A | Wang W
